It is increasingly recognized by providers that patients and their families seek to reduce the stigma of alcoholic liver disease, and a change from the term "alcoholic" to "alcohol-related" will help; thus, alcohol-related liver disease, alcohol-related steatohepatitis, and alcohol-related cirrhosis are suggested, retaining the familiar abbreviations (ALD, ASH, and AC, respectively).
Toward the main theme of "Frontiers in ASH, NASH, NBNC-HCC and PDAC", this platform showcased presentations by 12 invited international and Japanese speakers on brain-gut-liver interactions, emerging mechanisms of ASH and NASH, metabolic reprogramming, and new therapeutic targets for cirrhosis, HCC, and PDAC.